Candel Therapeutics Inc
NASDAQ:CADL 3:59:59 PM EDT
Earnings Announcements
Candel Therapeutics Reports Q2 Results
Published: 09/08/2021 12:31 GMT
Candel Therapeutics Inc (CADL) - Candel Therapeutics Reports Second Quarter 2021 Financial Results and Recent Corporate Highlights.
Revenue is expected to be $0.01 Million
Adjusted EPS is expected to be -$0.26
Next Quarter Revenue Guidance is expected to be $0.01 Million
Next Quarter EPS Guidance is expected to be -$0.25
More details on our Analysts Page.
Adjusted EPS is expected to be -$0.26
Next Quarter Revenue Guidance is expected to be $0.01 Million
Next Quarter EPS Guidance is expected to be -$0.25
More details on our Analysts Page.